A European Project For Precision Psychiatry: This Company Is Using AI To Predict Mental Health Disorders
Daniel Gehrlach, Ph.D. is the associate director of biomarkers at HMNC Brain Health, a biopharma company using genetic analyses and AI to predict and treat mental health disorders through individually tailored interventions.
